MediBeacon
PrivateLast Round
Convertible Debt
Jun 30, 2024
Est. Valuation
$410M
Total Funding Raised
$28.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MediBeacon operates in Healthcare & Life Sciences and is based in Saint Louis, Michigan. Its latest recorded funding round was a Convertible Debt round in June 2024.
MediBeacon is a medical technology company that develops fluorescent tracer agents and transdermal detection systems for real-time, point-of-care monitoring of organ function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sensors, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MediBeacon Comparables
Compare MediBeacon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FAST BioMedical | 78% | |
| Accunea Ltd | 71% | |
| Renify Technologies Private Limited | 69% |
For institutional investors. Book with your work email.
MediBeacon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jun 30, 2024 | ||||
| Convertible Debt | Sep 30, 2023 | ||||
| Corporate Funding | Nov 16, 2022 | ||||
| Corporate Funding | Jul 31, 2019 | ||||
| Grant | Oct 18, 2016 | ||||
VC Round | Aug 26, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MediBeacon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Missouri Technology Corporation | VC Round |
| BioGenerator Ventures | VC Round |
| Helix Fund | VC Round |
| Bill & Melinda Gates Foundation | Grant |
| Jump Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 37% MoM.
- Jun 18, 2026
Monthly visitors increased 73% MoM.
For institutional investors. Book with your work email.
MediBeacon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MediBeacon's valuation, stock price, and market status.
Is MediBeacon a public or private company?
MediBeacon is a private company.
What is the current stock price of MediBeacon?
MediBeacon is a private company, so its shares have no public market price. Caplight tracks MediBeacon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MediBeacon worth (valuation)?
MediBeacon's valuation is estimated at $410.0M based on funding round data.
Can I buy MediBeacon stock?
MediBeacon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MediBeacon's last funding round?
MediBeacon's most recent funding round was Convertible Debt on June 30, 2024.
Who are the main investors in MediBeacon?
Key investors in MediBeacon include Missouri Technology Corporation, BioGenerator Ventures, Helix Fund, Bill & Melinda Gates Foundation, Jump Capital.
Will MediBeacon IPO soon?
No public IPO plans have been announced for MediBeacon.
How can I track MediBeacon secondary market activity?
Caplight tracks bids, offers, and trades in MediBeacon's shares on secondary markets.